A Study to see how safe is RO7567132 as Single Agent and in Combination with Atezolizumab, how the body gets rid of it and how effective it is in people with Advanced and/or Metastatic Solid Tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512839-70-00

Acronym

BP44956

Enrollment

Registered

2024-07-24

Start date

2024-08-27

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced and/or Metastatic Solid Tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Denmark, France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026